Cancer disappears in every patient during experimental immunotherapy treatment trial

Cancer disappears in every patient during experimental immunotherapy treatment trial

All 12 individuals’ cancers went into remission, and the disease was declared undetectable. One of the primary authors stated, “This is the first time this has happened in the history of cancer.”

A trial involving patients with locally advanced rectal cancer saw six months of treatment with a drug called dostarlimab.

All 12 patients’ cancers went into remission, and endoscopy, physical tests, and scans revealed that they were undetectable.

“This is the first time this has happened in the history of cancers,” Dr. Luis Diaz, one of the study’s lead authors and an oncologist at Memorial Sloan Kettering Cancer Center, told The New York Times.

Despite the findings, doctors cautioned that further research and analysis are needed; nonetheless, the cancer has not returned in any of the patients since the trial finished.

The drug from the pharmaceutical company GlaxoSmithKline is used in the treatment of endometrial cancers and was given to each patient in the New York-led trial every three weeks.

Scientists have said these types of drugs are also used in other treatment – such as for melanoma – and do not target the cancer cells directly, but allow a person’s immune system to identify and destroy them.

For MORE: CLICK HERE

2 thoughts on “Cancer disappears in every patient during experimental immunotherapy treatment trial

  1. Good day! I could have sworn I’ve been to this blog before but after checking through some of the post I realized it’s new to me. Anyways, I’m definitely happy I found it and I’ll be book-marking and checking back often!

Leave a Reply

Your email address will not be published.